UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012590
Receipt number R000014726
Scientific Title The retrospective study of treatment by thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis, acute respiratory distress sydmrome
Date of disclosure of the study information 2014/01/01
Last modified on 2013/12/16 11:41:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The retrospective study of treatment by thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis, acute respiratory distress sydmrome

Acronym

The treatment of thrombomodulin for acute respiratory failure

Scientific Title

The retrospective study of treatment by thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis, acute respiratory distress sydmrome

Scientific Title:Acronym

The treatment of thrombomodulin for acute respiratory failure

Region

Japan


Condition

Condition

acute exacerbations of idiopathic pulmonary fibrosis, acute respiratory distress syndrome

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

the additional administration of rhTM for AE-IPF-patients has any beneficial effects on outocome, inflammatory mediators and activated coagulation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

The outcomes of patients included the 28-day mortality and in-hospital mortality after beginning treatment with rhTM were compared with those of untreated patients.

Key secondary outcomes

We investigated whether or not they showed any improvement in oxygenation (SpO2/FIO2) and intravascular coagulation disturbance (TAT, FDP) in the acute phase.


Base

Study type


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Thrombomodulin

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

The diagnosis of AE-IPF was based on the criteria, which state that all of the following three conditions must be satisfied during the course of IPF with an unexplained worsening of dyspnea within one month: (1) increased dyspnea, (2) new HRCT appearance, (3) greater than 10-mmHg decreases in oxygen partial pressure (PaO2) in the resting arterial blood compared to previous measurements. The typical HRCT appearance of AE-IPF involved ground glass opacity and/or consolidation as a new appearance on honeycombing. The criteria for the diagnosis of ARDS, as set by the Berlin Definition

Key exclusion criteria

The AE-IPF-patients were excluded if they had obvious signs of infection, preexisting pulmonary embolisms, left heart failure, pulmonary hypertension due to pulmonary thromboemboli or phlebitis based on the findings of color Doppler ultrasonography or enhanced HRCT.
Patient or family refusal for invasive mechanical ventilation was an exclusionary criterion for endotracheal intubation. Such patients were excluded from this study.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koichiro Tatsumi

Organization

Chiba University

Division name

Department of Respirology, Graduate School of Medicine

Zip code


Address

1-8-1 Inohana Chuo-ku Chiba 260-8670 Japan

TEL

043-226-2800

Email

tatsumi@faculty.chiba-u.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kenji Tsushima

Organization

Chiba University

Division name

Department of Respirology, Graduate School of Medicine

Zip code


Address

1-8-1 Inohana Chuo-ku Chiba 260-8670 Japan

TEL

043-226-2800

Homepage URL


Email

tsushimakenji@yahoo.co.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

Department of Respirology, Graduate School of Medicine, Chiba University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

ShinonoiGeneral Hospital
First Department of Internal Medicine, Shinshu University School of Medicine

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2010 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 12 Month 16 Day

Last modified on

2013 Year 12 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014726


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name